American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 59-69, July 2009

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Received 25 February 2009; accepted 10 April 2009. published online 08 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 A list of author affiliations appears at the end of this article.

 Originally published online as doi:10.1053/j.ajkd.2009.04.008 on June 8, 2009.

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Peter McCullough, MD, MPH, William Beaumont Hospital) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

 A list of the TREAT Investigators is provided as online supplementary material for this article.

 Trial Registration: www.clinicaltrials.gov; study number: NCT00093015.

PII: S0272-6386(09)00640-4

doi:10.1053/j.ajkd.2009.04.008

American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 59-69, July 2009

Article Tools